Literature DB >> 15684050

Parkin-deficient mice are not a robust model of parkinsonism.

Francisco A Perez1, Richard D Palmiter.   

Abstract

Mutations in the human parkin gene cause autosomal recessive juvenile parkinsonism, a heritable form of Parkinson's disease (PD). To determine whether mutations in the mouse parkin gene (Park2) also result in a parkinsonian phenotype, we generated mice with a targeted deletion of parkin exon 2. Using an extensive behavioral screen, we evaluated neurological function, motor ability, emotionality, learning, and memory in aged Parkin-deficient mice. The behavioral profile of Parkin-deficient mice on a B6;129S4 genetic background was strikingly similar to that of control mice, and most differences were not reproducible by using coisogenic mice on a 129S4 genetic background. Moreover, catecholamine levels in the striatum, olfactory bulb, and spinal cord of Parkin-deficient mice were normal. In contrast to previous studies using independently generated Parkin-deficient mice, we found no evidence for nigrostriatal, cognitive, or noradrenergic dysfunction. Understanding why Parkin-deficient mice do not exhibit robust signs of parkinsonism could advance knowledge and treatment of PD.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15684050      PMCID: PMC548311          DOI: 10.1073/pnas.0409598102

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  42 in total

1.  Origin of the mutations in the parkin gene in Europe: exon rearrangements are independent recurrent events, whereas point mutations may result from Founder effects.

Authors:  M Periquet; C Lücking; J Vaughan; V Bonifati; A Dürr; G De Michele; M Horstink; M Farrer; S N Illarioshkin; P Pollak; M Borg; C Brefel-Courbon; P Denefle; G Meco; T Gasser; M M Breteler; N Wood; Y Agid; A Brice
Journal:  Am J Hum Genet       Date:  2001-02-14       Impact factor: 11.025

2.  Mapping of quantitative trait loci with knockout/congenic strains.

Authors:  V J Bolivar; M N Cook; L Flaherty
Journal:  Genome Res       Date:  2001-09       Impact factor: 9.043

3.  Parkin suppresses unfolded protein stress-induced cell death through its E3 ubiquitin-protein ligase activity.

Authors:  Y Imai; M Soda; R Takahashi
Journal:  J Biol Chem       Date:  2000-11-17       Impact factor: 5.157

4.  Electrophysiological characterisation of the dentate gyrus in five inbred strains of mouse.

Authors:  E T Bampton; R A Gray; C H Large
Journal:  Brain Res       Date:  1999-09-11       Impact factor: 3.252

5.  Strain-specific effects of amphetamine on prepulse inhibition and patterns of locomotor behavior in mice.

Authors:  R J Ralph; M P Paulus; M A Geyer
Journal:  J Pharmacol Exp Ther       Date:  2001-07       Impact factor: 4.030

6.  Parkin functions as an E2-dependent ubiquitin- protein ligase and promotes the degradation of the synaptic vesicle-associated protein, CDCrel-1.

Authors:  Y Zhang; J Gao; K K Chung; H Huang; V L Dawson; T M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2000-11-21       Impact factor: 11.205

7.  Loss of locus coeruleus neurons and reduced startle in parkin null mice.

Authors:  Rainer Von Coelln; Bobby Thomas; Joseph M Savitt; Kah Leong Lim; Masayuki Sasaki; Ellen J Hess; Valina L Dawson; Ted M Dawson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

8.  parkin mutation analysis in clinic patients with early-onset Parkinson [corrected] disease.

Authors:  P Poorkaj; J G Nutt; D James; S Gancher; T D Bird; E Steinbart; G D Schellenberg; Haydeh Payami
Journal:  Am J Med Genet A       Date:  2004-08-15       Impact factor: 2.802

9.  A new continuous alternation task in T-maze detects hippocampal dysfunction in mice. A strain comparison and lesion study.

Authors:  R Gerlai
Journal:  Behav Brain Res       Date:  1998-09       Impact factor: 3.332

10.  Mitochondrial dysfunction and oxidative damage in parkin-deficient mice.

Authors:  James J Palacino; Dijana Sagi; Matthew S Goldberg; Stefan Krauss; Claudia Motz; Maik Wacker; Joachim Klose; Jie Shen
Journal:  J Biol Chem       Date:  2004-02-24       Impact factor: 5.157

View more
  177 in total

Review 1.  Parkinson's disease: a rethink of rodent models.

Authors:  Heather L Melrose; Sarah J Lincoln; Glenn M Tyndall; Matthew J Farrer
Journal:  Exp Brain Res       Date:  2006-04-26       Impact factor: 1.972

Review 2.  Redefining Parkinson's disease research using induced pluripotent stem cells.

Authors:  Jiali Pu; Houbo Jiang; Baorong Zhang; Jian Feng
Journal:  Curr Neurol Neurosci Rep       Date:  2012-08       Impact factor: 5.081

3.  Altered hippocampal synaptic physiology in aged parkin-deficient mice.

Authors:  Jesse E Hanson; Adrienne L Orr; Daniel V Madison
Journal:  Neuromolecular Med       Date:  2010-03-16       Impact factor: 3.843

Review 4.  Genetically engineered mouse models of Parkinson's disease.

Authors:  Donna M Crabtree; Jianhua Zhang
Journal:  Brain Res Bull       Date:  2011-08-03       Impact factor: 4.077

5.  Myristoylation confers noncanonical AMPK functions in autophagy selectivity and mitochondrial surveillance.

Authors:  Jiyong Liang; Zhi-Xiang Xu; Zhiyong Ding; Yiling Lu; Qinghua Yu; Kaitlin D Werle; Ge Zhou; Yun-Yong Park; Guang Peng; Michael J Gambello; Gordon B Mills
Journal:  Nat Commun       Date:  2015-08-14       Impact factor: 14.919

6.  Parkin controls dopamine utilization in human midbrain dopaminergic neurons derived from induced pluripotent stem cells.

Authors:  Houbo Jiang; Yong Ren; Eunice Y Yuen; Ping Zhong; Mahboobe Ghaedi; Zhixing Hu; Gissou Azabdaftari; Kazuhiro Nakaso; Zhen Yan; Jian Feng
Journal:  Nat Commun       Date:  2012-02-07       Impact factor: 14.919

7.  Cre recombinase-mediated restoration of nigrostriatal dopamine in dopamine-deficient mice reverses hypophagia and bradykinesia.

Authors:  Thomas S Hnasko; Francisco A Perez; Alex D Scouras; Elizabeth A Stoll; Samuel D Gale; Serge Luquet; Paul E M Phillips; Eric J Kremer; Richard D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  2006-05-24       Impact factor: 11.205

8.  Loss-of-function of human PINK1 results in mitochondrial pathology and can be rescued by parkin.

Authors:  Nicole Exner; Bettina Treske; Dominik Paquet; Kira Holmström; Carola Schiesling; Suzana Gispert; Iria Carballo-Carbajal; Daniela Berg; Hans-Hermann Hoepken; Thomas Gasser; Rejko Krüger; Konstanze F Winklhofer; Frank Vogel; Andreas S Reichert; Georg Auburger; Philipp J Kahle; Bettina Schmid; Christian Haass
Journal:  J Neurosci       Date:  2007-11-07       Impact factor: 6.167

9.  Overinhibition of corticostriatal activity following prenatal cocaine exposure.

Authors:  Wengang Wang; Ioana Nitulescu; Justin S Lewis; Julia C Lemos; Ian J Bamford; Natasza M Posielski; Granville P Storey; Paul E M Phillips; Nigel S Bamford
Journal:  Ann Neurol       Date:  2012-12-07       Impact factor: 10.422

10.  Identification and characterization of a novel endogenous murine parkin mutation.

Authors:  Chenere P Ramsey; Benoit I Giasson
Journal:  J Neurochem       Date:  2010-01-20       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.